Two Women Arrested With Banned Medicines, Carrying To Nepal

Motihari: Birgunj Police of Nepal has detained 2 women along with banned medicines. Sentinel Deputy Superintendent Kumar Vikram Thapa said that this action was taken near Rajat Jayanti Chowk of Ward No. 16. While checking the passenger train coming from Raxaul towards Birgunj, the sentry post Inerva suspected the presence of banned drugs.

After this, two women residents of Ramgarhwa were detained on the basis of suspicion. When examined, Buprenorphine 144 ampoules, Diazepam 149 ampoules and Phenergan 131 ampoules were recovered from the woman. Apart from this, Buprenorphine 148 ampoules, Diazepam 147 ampoules and Phenergan 147 ampoules were recovered from the other woman.

SOURCE : Dainik Bhaskar

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre